Global Immune Technologies Inc. - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - November 29, 2012



Attached files
FileFilename
EX-31.1 - EXHIBIT 31.1 - Global Immune Technologies Inc.v329129_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - Global Immune Technologies Inc.v329129_ex31-2.htm
EX-32.2 - EXHIBIT 32.2 - Global Immune Technologies Inc.v329129_ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - Global Immune Technologies Inc.v329129_ex32-1.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.R1.htm
EXCEL - IDEA: XBRL DOCUMENT - Global Immune Technologies Inc.Financial_Report.xls
10-Q - FORM 10-Q - Global Immune Technologies Inc.v329129_10q.htm
v2.4.0.6
Net Loss per Share (Details) (USD $)
3 Months Ended 6 Months Ended 12 Months Ended 162 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2010
Mar. 31, 2009
Mar. 31, 2008
Mar. 31, 2007
Mar. 31, 2006
Mar. 31, 2005
Mar. 31, 2004
Mar. 31, 2003
Mar. 31, 2002
Mar. 31, 2001
Mar. 31, 2000
Sep. 30, 2012
Net loss $ (67,377) $ (7,500) $ (77,710) $ (15,000) $ (65,142) $ (172,433) $ (61,020) $ (53,401) $ (134,274) $ (73,765) $ (94,957) $ (140,582) $ (106,831) $ (79,105) $ (613,406) $ (253,077) $ (563,508) $ (2,489,211)
Weighted average shares outstanding (in shares) 23,890,153 23,890,153 23,890,153 23,890,153                            
Basic & diluted loss per share (in dollars per share) $ 0.00 $ 0.00 $ 0.00 $ 0.00                            

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by Global Immune Technologies Inc. and has no official or unofficial affiliation with Global Immune Technologies Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.